Alliance QUANTUM Trial to Study Bispecific Immunotherapy for Rare Leukemia
New trial evaluates whether post-transplant consolidation therapy with teclistamab can improve survival in patients with primary plasma cell leukemia The Alliance for Clinical Trials in Oncology today announced the activation of The QUANTUM Trial (Alliance A062401), a clinical study designed to test a novel, immune-targeting approach for patients newly diagnosed with primary plasma cell leukemia…